Clinical Trials
Showing of 28 results
What prevents more cancer patients from enrolling in potentially life-saving clinical trials?
Financial barriers are biggest hurdle, according to new Case Western Reserve University and University Hospitals study.
Support from Harrington Discovery Institute at University Hospitals Helped Advance Heart Attack Drug into Clinical Trials
Positive results of zalunfiban announced at AHA Scientific Sessions.
Randomized Clinical Trial Led by University Hospitals Seidman Cancer Center Oncologist Leads to Practice-Changing Precision Prostate Cancer Therapy
Randomized trial validates first biomarker tool to guide hormone treatment decisions, allowing for more personalized prostate cancer care.
Kathy Coleman Commits Additional $3.5 Million to Fuel the Future of Clinical Trials at University Hospitals Seidman Cancer Center
UH plans to triple clinical trials capacity by 2030.
UH Cleveland Medical Center Currently Recruiting People with Early Alzheimer’s Disease for a Clinical Trial Evaluating Benfotiamine, a Synthetic Version of Thiamine (Vitamin B1)
Phase 2 study funded by the National Institute on Aging, part of the NIH, is evaluating effects of benfotiamine on cognitive function.
New Scientific Research Sheds Light on the Role of Vitamins K2 MK-7 and D3 in Alleviating Long COVID Symptoms
A groundbreaking clinical trial conducted by University Hospitals and published in the peer-reviewed journal Nutrients has revealed that a daily dose of vitamin D3 and vitamin K2 MK-7 could help improve symptoms of long COVID.
Researchers at University Hospitals, Case Western Reserve to begin clinical testing with new, less-invasive technology to screen for esophageal precancer
Study supported by $8 million National Institutes of Health grant.
Cholesterol Drug Repurposed as Investigational Therapy for HPV+ Cancers at University Hospitals Seidman Cancer Center in Nation’s First-Ever Clinical Trials
UH Seidman Cancer Center will soon begin to look into the use of fenofibrate as a potential treatment for HPV+ cancers.